{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:56Z","timestamp":1785560276816,"version":"3.56.0"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.2169\/internalmedicine.6395-25","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T22:26:34Z","timestamp":1766615194000},"page":"2142-2148","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal Changes in Structural and Functional Brain Imaging and Their Association with Cognitive and Neuropsychiatric Symptoms in Hashimoto Encephalopathy with Anti-NAE Antibody"],"prefix":"10.2169","volume":"65","author":[{"given":"Takaki","family":"Akahane","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Okitama Public General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Okitama Public General Hospital, Japan"},{"name":"Department of Psychiatry, Yamagata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yamagata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Okitama Public General Hospital, Japan"},{"name":"Department of Psychiatry, Yamagata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Akiho","sequence":"additional","affiliation":[{"name":"Department of Radiology, Okitama Public General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Okitama Public General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Shirata","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yamagata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yamagata University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsunaga A, Ikawa M, Yoneda M. Hashimoto encephalopathy. Clin Exp Neuroimmunol 10: 226-233, 2019.","DOI":"10.1111\/cen3.12543"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsunaga A, Ikawa M, Yoneda M. Expanding clinical spectrum from Hashimoto&apos;s encephalopathy to anti-NAE antibody-associated disorders (NAEAD). Clin Exp Neuroimmunol 15: 21-31, 2024.","DOI":"10.1111\/cen3.12772"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Waliszewska-Pros\u00f3\u0142 M, Ejma M. Hashimoto encephalopathy - still more questions than answers. Cells 11: 2873, 2022.","DOI":"10.3390\/cells11182873"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W. Hashimoto encephalopathy: a brainstem vasculitis? Neurology 54: 769-770, 2000.","DOI":"10.1212\/WNL.54.3.769"},{"key":"5","unstructured":"5. Chaudhuri A, Behan PO. The clinical spectrum, diagnosis, pathogenesis and treatment of Hashimoto&apos;s encephalopathy (recurrent acute disseminated encephalomyelitis). Curr Med Chem 10: 1945-1953, 2003."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mitoma H, Yoneda M, Saitow F, et al. Presynaptic dysfunction caused by cerebrospinal fluid from a patient with the ataxic form of Hashimoto&apos;s encephalopathy. Neurol Clin Neurosci 2: 104-108, 2014.","DOI":"10.1111\/ncn3.105"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fujii A, Yoneda M, Ito T, et al. Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto&apos;s encephalopathy. J Neuroimmunol 162: 130-136, 2005.","DOI":"10.1016\/j.jneuroim.2005.02.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of \u03b1-enolase in Hashimoto&apos;s encephalopathy. J Neuroimmunol 185: 195-200, 2007.","DOI":"10.1016\/j.jneuroim.2007.01.018"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kishitani T, Matsunaga A, Ikawa M, et al. Limbic encephalitis associated with anti-NH<sub>2<\/sub>-terminal of \u03b1-enolase antibodies: a clinical subtype of Hashimoto encephalopathy. Medicine (Baltimore) 96: e6181, 2017.","DOI":"10.1097\/MD.0000000000006181"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Matsunaga A, Ikawa M, Kawamura Y, et al. Serial brain MRI changes related to autoimmune pathophysiology in Hashimoto encephalopathy with anti-NAE antibodies: a case-series study. J Neurol Sci 406: 116453, 2019.","DOI":"10.1016\/j.jns.2019.116453"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Muramatsu T, Ikawa M, Yoneda M, et al. Pathophysiological decrease in the regional cerebral blood flow in Hashimoto&apos;s encephalopathy: a multiple-case SPECT study. Eur Neurol 72: 13-19, 2014.","DOI":"10.1159\/000358220"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nagano M, Kobayashi K, Yamada-Otani M, et al. Hashimoto&apos;s encephalopathy presenting with smoldering limbic encephalitis. Intern Med 58: 1167-1172, 2019.","DOI":"10.2169\/internalmedicine.1289-18"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yamaguchi Y, Wada M, Tanji H, et al. Steroid-responsive thalamic lesions accompanying microbleeds in a case of Hashimoto&apos;s encephalopathy with autoantibodies against \u03b1-enolase. Intern Med 52: 1249-1253, 2013.","DOI":"10.2169\/internalmedicine.52.9373"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ishitobi M, Yoneda M, Ikawa M, et al. Hashimoto&apos;s encephalopathy with hippocampus involvement detected on continuous arterial spin labeling. Psychiatry Clin Neurosci 67: 128-129, 2013.","DOI":"10.1111\/pcn.12019"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okitsu M, Sugaya K, Yoneda M, Takahashi K. Hashimoto encephalopathy presenting with acute psychosis and inappropriate secretion of antidiuretic hormone: a rare case responding to steroid therapy. Am J Case Rep 24: e942297, 2023.","DOI":"10.12659\/AJCR.942297"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Otsuka J, Hida A, Ogyu K, Minamimoto R, Takeuchi S. Improved <sup>123<\/sup>I-ioflupane binding after immunotherapy in anti-NAE antibody-positive Hashimoto encephalopathy that clinically mimicked multiple system atrophy. Clin Nucl Med 42: e390-e391, 2017.","DOI":"10.1097\/RLU.0000000000001728"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mizuma A, Goto Y, Takahashi W, Takizawa S, Takagi S. A patient with Hashimoto&apos;s encephalopathy presenting with convulsive seizure alone as the initial symptom. Clin Med Insights Case Rep 6: 75-77, 2013.","DOI":"10.4137\/CCRep.S10390"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takahashi N, Shikama Y, Kawahara H, Okabe Y, Kurimura M, Ohta Y. A case of Hashimoto&apos;s encephalopathy with acute onset of psychiatric symptoms and diffuse deep white matter lesions on brain MRI. Rinsho Shinkeigaku (Clin Neurol) 64: 171-175, 2024 (in Japanese).","DOI":"10.5692\/clinicalneurol.cn-001905"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE. Hashimoto&apos;s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers - report of 5 cases. Neurology 41: 228-233, 1991.","DOI":"10.1212\/WNL.41.2_Part_1.228"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Seeley WW. The salience network: a neural system for perceiving and responding to homeostatic demands. J Neurosci 39: 9878-9882, 2019.","DOI":"10.1523\/JNEUROSCI.1138-17.2019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hornberger M, Savage S, Hsieh S, Mioshi E, Piguet O, Hodges JR. Orbitofrontal dysfunction discriminates behavioral variant frontotemporal dementia from Alzheimer&apos;s disease. Dement Geriatr Cogn Disord 30: 547-552, 2010.","DOI":"10.1159\/000321670"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology 71: 736-742, 2008.","DOI":"10.1212\/01.wnl.0000324920.96835.95"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Leech R, Sharp DJ. The role of the posterior cingulate cortex in cognition and disease. Brain 137 (Pt 1): 12-32, 2014.","DOI":"10.1093\/brain\/awt162"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Baradaran N, Tan SN, Liu A, et al. Parkinson&apos;s disease rigidity: relation to brain connectivity and motor performance. Front Neurol 4: 67, 2013.","DOI":"10.3389\/fneur.2013.00067"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zhang S, Mao C, Li X, Miao W, Teng J. Advances in potential cerebrospinal fluid biomarkers for autoimmune encephalitis: a review. Front Neurol 13: 746653, 2022.","DOI":"10.3389\/fneur.2022.746653"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shimizu F, Nakamori M. Blood-brain barrier disruption in neuroimmunological disease. Int J Mol Sci 25: 10625, 2024.","DOI":"10.3390\/ijms251910625"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6395-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:45Z","timestamp":1785557625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/15\/65_6395-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":26,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6395-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"6395-25"}}